Research Grade Inotuzumabc (DHD38502)
- Product NameResearch Grade Inotuzumabc (DHD38502)
- CAS1660159-36-3
- CBNumberCB112402134
- MW0
- MOL FileMol file
Chemical Properties
| form | Liquid |
| color | Colorless to light yellow |
Research Grade Inotuzumabc (DHD38502) Chemical Properties,Usage,Production
Uses
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1][2][3][4].in vivo
Inotuzumab ozogamicin (100 μg/kg, i.p., twice a week for 2 weeks) combined with Venetoclax (HY-15531), Dexamethasone (HY-14648) induces long-term survival in murine patient-derived xenograft (PDX) models[3].
Inotuzumab (0.27, 3.2 mg/kg, i.p., a single dose for 400 h) inhibits tumor growth in mouse xenograft models[4].
| Animal Model: | Mouse xenograft models[4]. |
| Dosage: | 0.27, 3.2 mg/kg |
| Administration: | i.p., a single dose for 400 h |
| Result: | Decreased the tumor volume in mouse xenograft models. |
References
[1] Aujla A, et al. Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res. 2019 Apr 11;7:9. DOI:10.1186/s40364-019-0160-4[2] Wynne J, et al. Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. Blood Adv. 2019 Jan 8;3(1):96-104. DOI:10.1182/bloodadvances.2018026211
[3] Kirchhoff H, et al. Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL. Blood. 2021 May 13;137(19):2657-2661. DOI:10.1182/blood.2020008544
[4] Betts AM, et al. Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin. AAPS J. 2016 Sep;18(5):1101-1116. DOI:10.1208/s12248-016-9929-7
Research Grade Inotuzumabc (DHD38502) Suppliers
Global(11)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 027-65279366 18108604356 | products@biolabreagent.com | 9864 | 58 | ||
| 021-65675885 18964387627 | customer_service@efebio.com | 11963 | 58 | ||
| 027-87531629 | Proteintech-CN@ptglab.com | 6276 | 58 | ||
| 18916372613 | yanzihan@shyuanye.com | 87240 | 60 | ||
| 6206333 13167063860 | anhua.mao@aladdin-e.com | 49546 | 58 | ||
| 18007167883 18007167883 | Service@mabnus.com | 921 | 58 | ||
| 1-631-485-4226; 16314854226 | info@bocsci.com | 9920 | 65 | ||
| 15002134094 | marketing@targetmol.cn | 29874 | 58 | ||
| 027-027-16602739303 16602739303 | 673003916@qq.com | 4951 | 58 | ||
| 010-60605840 | psaitong@jm-bio.com | 27756 | 58 |